Free Access Editorials
The 2012 Lush Prize Awards
Kelly A. BéruBé and Katy Brown
The Labelling of All Medicinal Products as Dependent on Animal Research would be a Minefield to be Avoided At All Costs
Transparency and Public Accountability on the Use of Non-Human Primates as Laboratory Animals Needs Actions, as Well as Words
The Increasing Use of Genetically-altered Animals Threatens the Credibility of Directive 2010/63/EU
When Using Animal Tests or Alternative Methods, We are Also Testing Ourselves
Computational Toxicology is Now Inseparable from Experimental Toxicology
Mark T.D. Cronin
FRAME and the Pharmaceutical Industry
Where does iPS Cell Technology Leave the Promoters of the Creation and Use of Admixed Animal–Human Embryos?
The Conflict over Animal Experimentation: Is the Field of Battle Changing?
The International Transport of Laboratory Animals: No Excuse for Biased Extremism of Any Kind
Ban on the Use of Great Apes as Laboratory Animals in the UK
China is Taking Steps Toward Alternatives to Animal Testing
Rodger Curren and Brian Jones
Animal Experimentation and the Labelling of Drugs
Toxicity Testing: The Need for New Maps for the Future
The Three Rs and Animal Experimentation — Documented Signs of Advancement, or of Stagnation?
Animal Experiments and Alternatives: Matters of Belief and Trust
Modern Alternative Approaches to the Problem of Drug-induced Livery Injury
Replacing Animal Experimentation: On Creating the Puzzles to be Solved
ATLA (Alternatives to Laboratory Animals): Past, Present and Future
The EU Commission’s Draft Report on Alternative (Nonanimal) Methods for Cosmetics Testing: Current Status and Future Prospects — 2010: A Missed Opportunity
ATLA — A Truly International Journal
Rita Seabra and Susan Trigwell
Alternative Methods: Servants of Two Masters
Adult Human Stem Cells and Toxicity Testing: Realising the Potential
Replacing the Animal Testing of Botulinum Toxin: Time to Smooth Out the Wrinkles
Replacing, Reducing and Refining Animal Experiments: Making Sound Progress, but Must Do Better
In Silico Toxicology Challenges for Pharmaceuticals: Complacency or Controversy?
Mark T.D. Cronin
21st centry drug development: advances, opportunities and challenges
Animal experimentation and the Three Rs: time for honest answers to some leading questions
Refinement: a sense of progress
Fifty years after Russell and Burch, toxicologists continue to ignore genetic variation in their test animals.
Animal Experimentation: Weighing the Benefits Against the Suffering
Animal–human hybridisation: progressing down the slippery slope
Advocates of Animal Experimentation: What’s in a Name?
Experiments on humans and animals: can the end justify the means?
The Production of Admixed Animal–Human Embryos: Is it Necessary, or Merely Desirable?
Animal experimentation: the need for deliberation and challenge